Geni Starts Studies on Boswellia Extract

July 29, 2002

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


Geni Starts Studies on Boswellia Extract

CARMEL, Ind.--Geni Inc. started a series ofpharmacokinetic studies on its Boswellia serrata extract, WokVel. Thestudies are designed to determine optimum dose and dosing schedule, correlateplasma concentrations with observed beneficial effects, look for adverse drugreactions and examine toxicity levels. Geni (www.geniherbs.com)anticipates releasing the results in late September.

The company also announced it is in the protocol stage ofdeveloping a study examining the effects of a proprietary formulation in themanagement of diabetes.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like